We are live on ! Find out more
KA

Kinnevik AB Portfolio holdings

AUM $65.6M
1-Year Est. Return 25.95%
This Fund
S&P 500
This Quarter Est. Return
+11.99%
1 Year Est. Return
-25.95%
3 Year Est. Return
-51.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$77.7M
AUM Growth
+$3.18M
Cap. Flow
-$4.24M
Cap. Flow %
-5.46%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
RXRX icon
Recursion Pharmaceuticals
RXRX
+$19.3M

Top Sells

Rank Stock Value
1
BBLN
Babylon Holdings Limited
BBLN
+$23.5M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.58B
$77.7M 100%
10,405,668
+2,752,607
+36% +$19.3M
BBLN
2
DELISTED
Babylon Holdings Limited
BBLN
– –
-4,617,340
Closed -$23.5M

Similar funds

TCP
Teleios Capital Partners Zug $65.7M AUM 48.76% 1-Year Est. Return
MMC
Mainsail Management Company Austin, Texas $66M AUM 18.6% 1-Year Est. Return
MIG
Mithril II GP Austin, Texas $64.5M AUM 360.75% 1-Year Est. Return
KAM
Kinney Asset Management Chicago, Illinois $67.1M AUM 29.09% 1-Year Est. Return
MA
MAS Advisors Miami, Florida $63.2M AUM 9.63% 1-Year Est. Return
EVP
Evergreen Venture Partners Tel Aviv, Israel $68.4M AUM 1.49% 1-Year Est. Return
TIM
Tikehau Investment Management Paris, France $68.4M AUM 23.35% 1-Year Est. Return
A
Atomvest Hong Kong $68.5M AUM 4.6% 1-Year Est. Return

Kinnevik AB's Q2 2023 Portfolio in Review

As of Q2 2023, Kinnevik AB held 2 positions worth $77.7M, up 4.3% from $74.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Kinnevik AB withdrew a net $4.24M in Q2 2023, closing 1 position. Its most notable exit was Babylon Holdings Limited, an estimated $23.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Kinnevik AB added an estimated $19.3M to Recursion Pharmaceuticals.

  • Kinnevik AB added most to Recursion Pharmaceuticals in Q2 2023, an estimated $19.3M increase.
  • Kinnevik AB fully exited Babylon Holdings Limited in Q2 2023, selling an estimated $23.5M.
  • Kinnevik AB's ten largest holdings make up 100% of its $77.7M portfolio in Q2 2023.
  • Kinnevik AB opened 0 new positions and closed 1 in Q2 2023.
  • Kinnevik AB's portfolio value rose 4.3% quarter-over-quarter to $77.7M.

Based on Kinnevik AB's 13F filing for Q2 2023, filed 25 Jul 2023.